The microbiome—a vast ecosystem of microbes within our bodies—is emerging as a foundational platform for health, influencing everything from immunity and digestion to mental health and drug response. Despite growing scientific evidence, the healthcare industry often treats it as a niche trend, limiting its potential. The article argues for a paradigm shift: to stop viewing the microbiome as a wellness product and start integrating it into diagnostics, chronic care, and personalized medicine. The future of healthcare, it suggests, may depend not on external innovation, but on unlocking the power of the microscopic world within us.
Trending
- Natera acquires Foresight Diagnostics for up to $450M (Medtech Dive)
- $4.2M CDC grant to increase colorectal cancer screening in Pennsylvania (PennState)
- Motility coding changes coming in the new year (AGA)
- Updated Crohn’s Disease Guideline Stresses Early Use of Advanced Drugs (Medscape)
- Check your final 2025 MIPS eligibility (AGA)
- Affordable Care Act subsidies appear likely to expire (Chief Healthcare Executive)
- AI scribes hold ‘transformative potential’ for improving physician burden, patient care (Healio)
- New York Gastroenterology Associates Taps Proscia for Digital Pathology (Bio.IT World)
